Similar articles

• Plasma renin activity during levodopa therapy. Significance of long- and short-term treatment.

  Sullivan JM, Nakano KK, Tyler HR. Sullivan JM, et al. JAMA. 1973 Jun 25;224(13):1726-9. JAMA. 1973. PMID: 4350838 No abstract available.
• Renin-aldosterone system in Parkinson's disease.

  Barbeau A, Gillo-Joffroy L, Boucher R, Nowaczynski W, Genest J. Barbeau A, et al. Science. 1969 Jul 18;165(3890):291-2. doi: 10.1126/science.165.3890.291. Science. 1969. PMID: 5787986
• Levodopa and physical therapy in treatment of patients with Parkinson's disease.

  Stern PH, McDowell F, Miller JM, Robinson M. Stern PH, et al. Arch Phys Med Rehabil. 1970 May;51(5):273-7. Arch Phys Med Rehabil. 1970. PMID: 5420013 No abstract available.
• Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa.

  Parkes JD, Marsden CD, Rees JE, Curzon G, Kantamaneni BD, Knill-Jones R, Akbar A, Das S, Kataria M. Parkes JD, et al. Q J Med. 1974 Jan;43(169):49-61. Q J Med. 1974. PMID: 4822972 No abstract available.
• [Results of treatment with levodopa and rehabilitative therapy in 10 cases of Parkinson's disease].

  Paciaroni E, Raspa EG. Paciaroni E, et al. Sist Nerv. 1970 Mar-Jun;22(2):153-61. Sist Nerv. 1970. PMID: 5504554 Italian. No abstract available.